A first in Asia
According to the Li Ka Shing Foundation, the three private hospitals will launch trials, with costs for 30 patients covered by the foundation. The aim is to evaluate the safety and effectiveness of histotripsy in treating kidney cancer, an area where the technology has not yet been used in Asia. Hong Kong has previously used it for liver and pancreatic tumours.
Sound waves instead of a scalpel
Histotripsy uses high-intensity focused ultrasound pulses to create tiny bubbles that mechanically break apart tumour tissue without surgery, radiation or chemotherapy. Doctors can monitor the procedure in real time through imaging, allowing precise targeting.














